Haleon makes Sensodyne, Advil and Centrum.
Haleon plc (HLN) is expected to report earnings on Thursday, March 4, 2027, after the close. Consensus EPS estimate is $0.29.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | FY2026 Q2 | $0.27 | $0.17 | — | $5.64B |
| 2026-04-29 | FY2026 Q1 | $0.25 | $0.26 | +3.4% | $7.51B |
| 2026-03-13 | FY2025 Q4 | — | $0.19 | — | $5.52B |
| 2025-10-30 | FY2025 Q3 | $0.13 | $0.12 | -2.6% | — |
| 2025-06-30 | FY2025 Q2 | $0.24 | $0.18 | — | $5.48B |
| 2025-03-31 | FY2024 Q4 | $0.22 | $0.09 | — | $2.74B |
| 2024-12-31 | FY2024 Q3 | $0.11 | $0.16 | — | $5.54B |
| 2024-09-30 | FY2024 Q2 | $0.09 | $0.11 | — | $2.78B |
HLN has beaten consensus EPS in 1 of its last 2 scored quarters.
HLN reported Jul 30. The highlights: EPS of $0.17 — a sharp miss vs the $0.27 estimate (-36%); revenue of $5.64B — a sharp miss vs the $7.43B consensus (-24%). Focus now shifts to category growth and power brands.
HLN pays a semi-annual dividend, currently yielding 2.04%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-08-14 | $0.0642 | 2026-09-17 |
| 2026-04-10 | $0.1333 | 2026-05-14 |
| 2025-08-15 | $0.0598 | 2025-09-18 |
| 2025-04-25 | $0.1166 | 2025-06-05 |
| 2024-08-16 | $0.0514 | 2024-09-19 |
| 2024-03-14 | $0.1064 | 2024-05-16 |